Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-030805
Filing Date
2024-10-07
Accepted
2024-10-07 16:07:03
Documents
1
Period of Report
2024-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1385
  Complete submission text file 0001437749-24-030805.txt   3116
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMUNON, INC. 997 LENOX DRIVE, SUITE 100 LAWRENCEVILLE NJ 08648
Business Address
Eylward Susan (Reporting) CIK: 0002039135 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 241357867